Skip to content

AIRITY: A hybrid cross-sectional and prospective study to assess patient characteristics, disease burden, disease control, phenotypes, endotypes, and outcomes in a real-world setting in patients with asthma

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524916-13-00
Enrollment
346
Registered
2026-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

1) Asthma control over time, including differences between people with well-controlled and poorly controlled asthma., 2) Changes in asthma treatment use, such as inhalers or other medicines., 3) Changes in lung function over time, based on repeated breathing tests, especially in groups defined by inflammation markers.

Detailed description

1) Asthma flare-ups, such as attacks needing extra medication, emergency care, or hospital visits., 2) Use of healthcare services, including doctor visits, emergency visits, and hospital stays., 3) Changes in asthma treatments, such as increases or decreases in medication use., 4) Other health conditions people with asthma may have and how severe they are., 5) Impact on daily life, including sleep quality, fatigue (tiredness), ability to do normal daily activities, and work or school productivity, 6) Patient and doctor views about asthma severity, symptom control, and satisfaction with treatment., 7) Changes in inflammation markers over time and how they relate to asthma symptoms and lung function.

Interventions

Sponsors

Sanofi-Aventis Recherche & Developpement
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
0 Years to No maximum

Design outcomes

Primary

MeasureTime frame
1) Asthma control over time, including differences between people with well-controlled and poorly controlled asthma., 2) Changes in asthma treatment use, such as inhalers or other medicines., 3) Changes in lung function over time, based on repeated breathing tests, especially in groups defined by inflammation markers.

Secondary

MeasureTime frame
1) Asthma flare-ups, such as attacks needing extra medication, emergency care, or hospital visits., 2) Use of healthcare services, including doctor visits, emergency visits, and hospital stays., 3) Changes in asthma treatments, such as increases or decreases in medication use., 4) Other health conditions people with asthma may have and how severe they are., 5) Impact on daily life, including sleep quality, fatigue (tiredness), ability to do normal daily activities, and work or school productivity, 6) Patient and doctor views about asthma severity, symptom control, and satisfaction with treatment., 7) Changes in inflammation markers over time and how they relate to asthma symptoms and lung function.

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 11, 2026